Urine Drug Testing of Chronic Pain Patients. V. Prevalence of Propoxyphene Following Its Withdrawal From the United States Market

Journal of Analytical Toxicology - United States
doi 10.1093/jat/bks083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

United States Withdrawal From the International Labor Organization

International Legal Materials
1977English

Prevalence of Multiple Chronic Conditions Among Medicare Beneficiaries, United States, 2010

Preventing chronic disease
Health PolicyPublic HealthOccupational HealthEnvironmental
2013English

Reply to “Necessity for Interrupted Time Series to Analyze the Effects of Propoxyphene Withdrawal From the Market and Further Health Outcome Trend Estimates”

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

The Burden of Osteoarthritis Pain From Patient’s Perspective in the United States

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United States

Journal of Urology
Urology
2011English

Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016

JAMA - Journal of the American Medical Association
Medicine
2016English

The United States Longevity Insurance Market

2011English

Prevalence of Arthritis—United States, 1997

JAMA - Journal of the American Medical Association
Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy